AU1366088A - Immunosuppressive peptides and methods of use - Google Patents

Immunosuppressive peptides and methods of use

Info

Publication number: AU1366088A
Authority: AU; Australia
Prior art keywords: methods; immunosuppressive peptides; immunosuppressive; peptides
Prior art date: 1987-01-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU13660/88A

Inventor

William S. Kloetzer

Robert B. Naso

John R. Warner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ortho Pharmaceutical Corp

Original Assignee

Ortho Pharmaceutical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-01-28

Filing date

1988-01-25

Publication date

1988-08-24

1988-01-25 Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp

1988-08-24 Publication of AU1366088A publication Critical patent/AU1366088A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Oncology (AREA)
Food Science & Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hospice & Palliative Care (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Analytical Chemistry (AREA)
Virology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Transplantation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AU13660/88A 1987-01-28 1988-01-25 Immunosuppressive peptides and methods of use Abandoned AU1366088A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US750987A	1987-01-28	1987-01-28
US007509		1987-01-28

Publications (1)

Publication Number	Publication Date
AU1366088A true AU1366088A (en)	1988-08-24

Family

ID=21726617

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU13660/88A Abandoned AU1366088A (en)	1987-01-28	1988-01-25	Immunosuppressive peptides and methods of use

Country Status (6)

Country	Link
EP (1)	EP0300031A4 (en)
JP (1)	JPH01501939A (en)
KR (1)	KR890700602A (en)
AU (1)	AU1366088A (en)
DK (1)	DK535988A (en)
WO (1)	WO1988005783A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8705197D0 (en) *	1987-12-30	1987-12-30	Jonas Blomberg	NEW PEPTIDES, TWO DIAGNOSTIC METHODS USING THE PEPTIDES AND A MEDICATION BASED ON THE PEPTIDES
EP0377842B1 (en) *	1988-12-13	1995-10-04	President And Fellows Of Harvard College	Prototype FeLV isolates for use in disease models and vaccines
US5061786A (en) *	1989-05-25	1991-10-29	Genentech, Inc.	Biologically active polypeptides based on transforming growth factor-β
US5268455A (en) *	1989-05-25	1993-12-07	Genentech, Inc.	Process for making biologically active polypeptides based on transforming growth factor-βsequences
JP2807287B2 (en) *	1989-10-13	1998-10-08	株式会社医学生物学研究所	Peptides and their uses
US5567805A (en) *	1990-03-09	1996-10-22	Administrators Of The Tulane Educational Fund	The cellular receptor for the CS3 peptide of human immunodeficiency virus
FR2677654B1 (en) *	1991-06-17	1995-11-17	Pasteur Merieux Serums Vacc	COMPOUNDS WITH AN IMMUNOGENIC ANTI-CYTOKIN EFFECT, AN ANTIYTOSTATIC IMMUNOGENIC EFFECT OR AN ANTI-HIV INFECTION VACCINE EFFECT.
ATE193208T1 (en) *	1992-02-10	2000-06-15	Univ Duke	USE OF SYNTHETIC PEPTIDES TO INDUCE TOLERANCE TO T AND B CELL EPITOPES OF AUTOANTIGENS
SE9202318L (en) *	1992-08-10	1994-02-11	Replico Medical Ab	New peptides, diagnostic antigens, their use, vaccines and drugs
CA2182388C (en)	1994-02-07	2007-08-07	Metin Colpan	Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
DE4405810A1 (en)	1994-02-23	1995-08-24	Behringwerke Ag	Peptides derived from a retrovirus from the HIV group and their use
SE9403526D0 (en)	1994-10-14	1994-10-14	Astra Ab	New Peptides
DZ1964A1 (en) *	1995-01-13	2002-10-15	Nika Health Products Ltd	New applications of a lysozyme dimer.
SE9501067D0 (en) *	1995-03-24	1995-03-24	Astra Ab	New peptides
US5994292A (en) *	1995-05-31	1999-11-30	The United States Of America As Represented By The Department Of Health And Human Services	Interferon-inducible protein 10 is a potent inhibitor of angiogenesis
WO1997039023A1 (en) *	1996-04-12	1997-10-23	Astra Aktiebolag	Cysteine-containing or methioine-containing peptides with immunomodulatory effects
WO1998010792A1 (en) *	1996-09-11	1998-03-19	Prendergast Patrick T	Immune direction therapy
SE9603461D0 (en) *	1996-09-23	1996-09-23	Astra Ab	New compounds
SE9603462D0 (en) *	1996-09-23	1996-09-23	Astra Ab	New compounds
SE9603468D0 (en) *	1996-09-23	1996-09-23	Astra Ab	New compounds
IT1307826B1 (en)	1999-12-16	2001-11-19	Dipartimento Di Medicina Speri	DIAGNOSTIC METHOD FOR THE RECOGNITION OF NORMAL ELEUCEMIC MYELOID CELLS, LIGANDS USED IN THAT METHOD AND FORMULATIONS FOR USE
US9777044B2 (en)	2003-05-02	2017-10-03	Centre National De La Recherche Scientifique (Cnrs)	GLUT-1 as a receptor for HTLV envelopes and its uses
DK1648926T3 (en)	2003-05-02	2013-10-14	Centre Nat Rech Scient	GLUT-1 AS A RECEPTOR FOR HTLV CAPS AND APPLICATIONS THEREOF
US20110104186A1 (en)	2004-06-24	2011-05-05	Nicholas Valiante	Small molecule immunopotentiators and assays for their detection
US9791435B2 (en)	2009-01-09	2017-10-17	Centre National De La Recherche Scientifique	Receptor binding ligands, their use in the detection of cells with biological interest

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4525300A (en) *	1983-01-07	1985-06-25	Japanese Foundation For Cancer Research	Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
GB8301928D0 (en) *	1983-01-24	1983-02-23	Nicholson B H	Process for producing polypeptides
US4663436A (en) *	1984-04-24	1987-05-05	Scripps Clinic And Research Foundation	Leukemia-associated virus immunogen, vaccine and assay
US4689398A (en) *	1984-06-20	1987-08-25	Ortho Diagnostic Systems Inc.	HTLV test using synthetic peptides
US4629783A (en) *	1985-04-29	1986-12-16	Genetic Systems Corporation	Synthetic antigen for the detection of AIDS-related disease
ATE116006T1 (en) *	1985-04-29	1995-01-15	Genetic Systems Corp	SYNTHETIC ANTIGENS FOR DETECTING AIDS.

1988
- 1988-01-25 AU AU13660/88A patent/AU1366088A/en not_active Abandoned
- 1988-01-25 EP EP19880902271 patent/EP0300031A4/en not_active Withdrawn
- 1988-01-25 WO PCT/US1988/000176 patent/WO1988005783A1/en not_active Ceased
- 1988-01-25 JP JP63502107A patent/JPH01501939A/en active Pending
- 1988-09-27 DK DK535988A patent/DK535988A/en not_active Application Discontinuation
- 1988-09-27 KR KR1019880701169A patent/KR890700602A/en not_active Withdrawn

Also Published As

Publication number	Publication date
DK535988D0 (en)	1988-09-27
EP0300031A4 (en)	1990-05-14
EP0300031A1 (en)	1989-01-25
WO1988005783A1 (en)	1988-08-11
KR890700602A (en)	1989-04-26
DK535988A (en)	1988-11-25
JPH01501939A (en)	1989-07-06

Publication	Publication Date	Title
AU1366088A (en)	1988-08-24	Immunosuppressive peptides and methods of use
AU585180B2 (en)	1989-06-08	Nor-statine and nor-cyclostatine polypeptides
AU3678489A (en)	1990-01-18	Alloy and methods of use thereof
AU1925588A (en)	1989-02-02	Blasting system and components therefor
AU3076189A (en)	1989-08-31	Novel compositions and methods of use thereof
AU2472188A (en)	1989-07-06	Multi-piece connector and receptacle therefor
AU4781693A (en)	1994-06-08	Camptothecin analogues and methods of preparation thereof
AU1069688A (en)	1988-07-28	Non natural demethylavermectins and process therefor
GB2216134B (en)	1992-08-12	Membranes and methods of preparation thereof
AU9092091A (en)	1992-06-11	Receptor recognition factor and methods of use thereof
AU6428890A (en)	1991-04-18	Therapeutic peptides and proteins
AU4687189A (en)	1990-06-21	Hydrophones and similar devices
AU633294B2 (en)	1993-01-28	Motilin-like polypeptide and use thereof
AU1382488A (en)	1988-09-29	Cyclic peptides and their preparation
AU5097790A (en)	1990-09-05	Cyclopentenyl pyrimidines and methods of using same
AU2584688A (en)	1989-09-28	Sectional container and method of assembly thereof
AU3270589A (en)	1989-12-07	Antiperspirant and method of making same
AU8427091A (en)	1992-02-18	Gamma-carboxylase and methods of use
IL87730A0 (en)	1989-02-28	Peptides and antibodies
AU610900B2 (en)	1991-05-30	Immunosuppressant peptides
AU3890689A (en)	1990-02-01	Human protein c mutants and method for preparing the same
AU576717B2 (en)	1988-09-01	N6 - bicycloadenosines and methods of use
AU3193089A (en)	1989-09-06	Prepromotilin and motilin-associated peptide (map)
AU1966688A (en)	1988-12-21	Immunosuppressive polypeptides
AU4588189A (en)	1990-06-21	Imidazole-containing peptide and preparation thereof